tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Financial Statements

Compare
335 Followers

Conduit Pharmaceuticals Financial Overview

Conduit Pharmaceuticals's market cap is currently $4.77M. The company's EPS TTM is $-21.066; its P/E ratio is ―; Conduit Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 2.46B$ 0.00$ 0.00$ 0.00
Gross Profit$ 922.22M$ 0.00$ 0.00$ 0.00
Operating Income$ 266.46M$ -5.56M$ -3.16M$ -3.17M
EBITDA$ 266.46M$ -324.00K$ -1.43M$ -4.38K
Net Income$ 198.43M$ -535.00K$ -4.89M$ -3.66M
Balance Sheet
Cash & Short-Term Investments$ 370.30M$ 4.23M$ 345.78K$ 48.55K
Total Assets$ 3.26B$ 7.22M$ 5.00K$ 213.13K
Total Debt$ 1.23B$ 985.00K$ 2.01M$ 749.00K
Net Debt$ 859.85M$ -3.24M$ 1.66M$ 700.45K
Total Liabilities$ 1.97B$ 7.68M$ 10.08M$ 5.94M
Stockholders' Equity$ 1.29B$ -457.00K$ -10.08M$ -5.94M
Cash Flow
Free Cash Flow$ 222.98M$ -7.72M$ -2.27M$ -2.15M
Operating Cash Flow$ 344.80M$ -7.72M$ -2.27M$ -2.15M
Investing Cash Flow$ -419.48M$ 725.00K$ -183.00K$ 48.55K
Financing Cash Flow$ -143.72M$ 10.93M$ 2.45M$ 1.90M
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

Conduit Pharmaceuticals Debt to Assets

Conduit Pharmaceuticals Cash Flow

Conduit Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis